(2-Hydroxypropyl)-β-cyclodextrin
CAS No. 128446-35-5
(2-Hydroxypropyl)-β-cyclodextrin( Hydroxypropyl betadex | Hydroxypropyl-β-cyclodextrin | HP-β-CD )
Catalog No. M23447 CAS No. 128446-35-5
(2-Hydroxypropyl)-β-cyclodextrin is a widely used drug delivery vehicle to improve stability and bioavailability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 31 | In Stock |
|
| 1G | 45 | In Stock |
|
Biological Information
-
Product Name(2-Hydroxypropyl)-β-cyclodextrin
-
NoteResearch use only, not for human use.
-
Brief Description(2-Hydroxypropyl)-β-cyclodextrin is a widely used drug delivery vehicle to improve stability and bioavailability.
-
Description(2-Hydroxypropyl)-β-cyclodextrin is a widely used drug delivery vehicle to improve stability and bioavailability.
-
In VitroCell treatment with HP-β-CD results in the activation of the transcription factor EB, a master regulator of lysosomal function and autophagy, and in enhancement of the cellular autophagic clearance capacity. HP-β-CD treatment reduces intracellular cholesterol resulting in significant leukemic cell growth inhibition through G2/M cell-cycle arrest and apoptosis. The IC50 values for HP-β-CD after 72 hours exposure are in the range of 3.86-10.09 mM. HP-β-CD also shows anticancer effects against CML cells expressing a T315I BCR-ABL mutation (that confers resistance to most ABL tyrosine kinase inhibitors), and hypoxia-adapted CML cells that have characteristics of leukemic stem cells. In addition, colony forming ability of human primary AML and CML cells is inhibited by HP-β-CD.
-
In VivoHP-β-CD administration promotes transcription factor EB-mediated clearance of proteolipid aggregates that accumulate due to inefficient activity of the lysosome-autophagy system in cells derived from a patient with a lysosomal storage disorder. Intraperitoneal injection of HP-β-CD significantly improves survival in leukemia mouse models. Systemic administration of HP-β-CD to mice has no significant adverse effects.
-
SynonymsHydroxypropyl betadex | Hydroxypropyl-β-cyclodextrin | HP-β-CD
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number128446-35-5
-
Formula Weight1541.5
-
Molecular FormulaC63H112O42
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL;H2O:50 mg/mL (Need ultrasonic)
-
SMILESCC(COC[C@H]1[C@H]2[C@H]([C@@H]([C@@H](O1)O[C@H]3[C@@H](O[C@H]([C@H]([C@@H]3O)O)O[C@H]4[C@@H](O[C@H]([C@H]([C@@H]4O)O)O[C@H]5[C@@H](O[C@H]([C@H]([C@@H]5O)O)O[C@H]6[C@@H](O[C@H]([C@H]([C@@H]6O)O)O[C@H]7[C@@H](O[C@H]([C@H]([C@@H]7O)O)O[C@H]8[C@@H](O[C@@H](O2)[C@H]([C@@H]8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Song W, et al. 2-Hydroxypropyl-β-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J Biol Chem. 2014 Apr 4;289(14):10211-22.
molnova catalog
related products
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
-
Justicidinoside C
The herbs of Phyllanthus piscatorum.
-
Traxanox
Traxanox is an orally available diuretic.Traxanox enhances phagocytosis of yeast granules by mouse peritoneal macrophages or rat peritoneal polymorphonuclear leukocytes in vitro.Restorative effect of Traxanox on inhibition of antibody production in BALB/c mice.
Cart
sales@molnova.com